Published in J Cereb Blood Flow Metab on April 01, 1986
Kinetic analysis in healthy humans of a novel positron emission tomography radioligand to image the peripheral benzodiazepine receptor, a potential biomarker for inflammation. Neuroimage (2007) 2.50
Brain and whole-body imaging in nonhuman primates of [11C]PBR28, a promising PET radioligand for peripheral benzodiazepine receptors. Neuroimage (2007) 1.91
Quantitation of cannabinoid CB1 receptors in healthy human brain using positron emission tomography and an inverse agonist radioligand. Neuroimage (2009) 1.42
Metabotropic glutamate subtype 5 receptors are quantified in the human brain with a novel radioligand for PET. J Nucl Med (2008) 1.37
Quantification of translocator protein (18 kDa) in the human brain with PET and a novel radioligand, (18)F-PBR06. J Nucl Med (2009) 1.36
Imaging and quantitation of cannabinoid CB1 receptors in human and monkey brains using (18)F-labeled inverse agonist radioligands. J Nucl Med (2009) 1.31
Kinetic analysis in human brain of [11C](R)-rolipram, a positron emission tomographic radioligand to image phosphodiesterase 4: a retest study and use of an image-derived input function. Neuroimage (2010) 1.31
A possible substrate for dopamine-related changes in mood and behavior: prefrontal and limbic effects of a D3-preferring dopamine agonist. Proc Natl Acad Sci U S A (2002) 1.22
Modeling pulmonary kinetics of 2-deoxy-2-[18F]fluoro-D-glucose during acute lung injury. Acad Radiol (2008) 1.09
Quantification of nicotinic acetylcholine receptors in human brain using [123I]5-I-A-85380 SPET. Eur J Nucl Med Mol Imaging (2003) 1.01
Kinetic analysis of [11C]befloxatone in the human brain, a selective radioligand to image monoamine oxidase A. EJNMMI Res (2013) 0.92
Brain and whole-body imaging in rhesus monkeys of 11C-NOP-1A, a promising PET radioligand for nociceptin/orphanin FQ peptide receptors. J Nucl Med (2011) 0.90
The PET Radioligand 18F-FIMX Images and Quantifies Metabotropic Glutamate Receptor 1 in Proportion to the Regional Density of Its Gene Transcript in Human Brain. J Nucl Med (2015) 0.84
Retest imaging of [11C]NOP-1A binding to nociceptin/orphanin FQ peptide (NOP) receptors in the brain of healthy humans. Neuroimage (2013) 0.83
Quantification of Lung PET Images: Challenges and Opportunities. J Nucl Med (2017) 0.81
11C-LY2428703, a positron emission tomographic radioligand for the metabotropic glutamate receptor 1, is unsuitable for imaging in monkey and human brains. EJNMMI Res (2013) 0.81
Quantitative analyses of regional [11C]PE2I binding to the dopamine transporter in the human brain: a PET study. Eur J Nucl Med Mol Imaging (2006) 0.81
Incorporation of MRI-AIF information for improved kinetic modelling of dynamic PET data. EJNMMI Phys (2014) 0.75
FDG kinetic modeling in small rodent brain PET: optimization of data acquisition and analysis. EJNMMI Res (2013) 0.75
[(11)C]TASP457, a novel PET ligand for histamine H3 receptors in human brain. Eur J Nucl Med Mol Imaging (2016) 0.75
Tomographic measurement of local cerebral glucose metabolic rate in humans with (F-18)2-fluoro-2-deoxy-D-glucose: validation of method. Ann Neurol (1979) 5.83
Positron emission tomography in evaluation of dementia: Regional brain metabolism and long-term outcome. JAMA (2001) 5.13
Positron emission tomography study of human brain functional development. Ann Neurol (1987) 4.89
Cerebral metabolic and cognitive decline in persons at genetic risk for Alzheimer's disease. Proc Natl Acad Sci U S A (2000) 4.85
A tabulated summary of the FDG PET literature. J Nucl Med (2001) 4.37
Apolipoprotein E type 4 allele and cerebral glucose metabolism in relatives at risk for familial Alzheimer disease. JAMA (1995) 4.02
Ketone-body utilization by adult and suckling rat brain in vivo. Biochem J (1971) 3.32
Performance evaluation of microPET: a high-resolution lutetium oxyorthosilicate PET scanner for animal imaging. J Nucl Med (1999) 3.31
A mutant herpes simplex virus type 1 thymidine kinase reporter gene shows improved sensitivity for imaging reporter gene expression with positron emission tomography. Proc Natl Acad Sci U S A (2000) 3.28
The FERM domain: a unique module involved in the linkage of cytoplasmic proteins to the membrane. Trends Biochem Sci (1998) 3.24
Quantitation in positron emission computed tomography: 1. Effect of object size. J Comput Assist Tomogr (1979) 3.18
The major facilitator superfamily. J Mol Microbiol Biotechnol (1999) 3.17
Noninvasive determination of local cerebral metabolic rate of glucose in man. Am J Physiol (1980) 3.12
Human pharmacokinetic and dosimetry studies of [(18)F]FHBG: a reporter probe for imaging herpes simplex virus type-1 thymidine kinase reporter gene expression. J Nucl Med (2001) 3.03
Imaging adenoviral-directed reporter gene expression in living animals with positron emission tomography. Proc Natl Acad Sci U S A (1999) 2.71
Cerebral hyperglycolysis following severe traumatic brain injury in humans: a positron emission tomography study. J Neurosurg (1997) 2.68
Regional brain metabolic changes in patients with major depression treated with either paroxetine or interpersonal therapy: preliminary findings. Arch Gen Psychiatry (2001) 2.67
Reduction of prefrontal cortex glucose metabolism common to three types of depression. Arch Gen Psychiatry (1989) 2.67
A simple method for the determination of oestrogen receptor concentrations in breast tumours and other tissues. Clin Chim Acta (1975) 2.64
Decision tree sensitivity analysis for cost-effectiveness of FDG-PET in the staging and management of non-small-cell lung carcinoma. J Nucl Med (1996) 2.60
Imaging of adenoviral-directed herpes simplex virus type 1 thymidine kinase reporter gene expression in mice with radiolabeled ganciclovir. J Nucl Med (1998) 2.58
Safety and tolerability of putaminal AADC gene therapy for Parkinson disease. Neurology (2009) 2.37
Effects of dobutamine stimulation on myocardial blood flow, glucose metabolism, and wall motion in normal and dysfunctional myocardium. Circulation (1996) 2.31
Oestrogen receptors and breast cancer: current status. Br J Surg (1980) 2.31
Estrogen secretion by the rat ovary in vivo during the estrous cycle and pregnancy. Endocrinology (1969) 2.25
Repetitive, non-invasive imaging of the dopamine D2 receptor as a reporter gene in living animals. Gene Ther (1999) 2.21
Infantile spasms: I. PET identifies focal cortical dysgenesis in cryptogenic cases for surgical treatment. Ann Neurol (1990) 2.12
A meta-analysis of the literature for whole-body FDG PET detection of recurrent colorectal cancer. J Nucl Med (2000) 2.10
Correlation of tumor and whole-body dosimetry with tumor response and toxicity in refractory neuroblastoma treated with (131)I-MIBG. J Nucl Med (2001) 2.04
Serum pepsinogens as a screening test of extensive chronic gastritis. Gastroenterol Jpn (1987) 2.03
Imaging transgene expression with radionuclide imaging technologies. Neoplasia (2000) 2.03
Local cerebral glucose metabolic rates in obsessive-compulsive disorder. A comparison with rates in unipolar depression and in normal controls. Arch Gen Psychiatry (1987) 1.98
Significance of aromatase activity in human breast cancer. Cancer Res (1982) 1.97
Application of annihilation coincidence detection to transaxial reconstruction tomography. J Nucl Med (1975) 1.97
Noninvasive methods for quantitating blood time-activity curves from mouse PET images obtained with fluorine-18-fluorodeoxyglucose. J Nucl Med (1998) 1.97
Positron emission tomography: human brain function and biochemistry. Science (1985) 1.92
A positron-emission transaxial tomograph for nuclear imaging (PETT). Radiology (1975) 1.87
Noninvasive quantitative imaging of protein-protein interactions in living subjects. Proc Natl Acad Sci U S A (2002) 1.85
The usefulness of F-18 deoxyglucose whole-body positron emission tomography (PET) for re-staging of renal cell cancer. Clin Nephrol (2002) 1.85
Thallium-201 SPECT imaging of brain tumors: methods and results. J Nucl Med (1990) 1.85
Reproducibility of measurements of oestrogen-receptor concentration in breast cancer. Br J Cancer (1977) 1.85
Noninvasive quantification of the cerebral metabolic rate for glucose using positron emission tomography, 18F-fluoro-2-deoxyglucose, the Patlak method, and an image-derived input function. J Cereb Blood Flow Metab (1998) 1.84
Evaluation of the skeletal kinetics of fluorine-18-fluoride ion with PET. J Nucl Med (1992) 1.83
Maturational changes in cerebral function in infants determined by 18FDG positron emission tomography. Science (1986) 1.81
Influence of age and hemodynamics on myocardial blood flow and flow reserve. Circulation (1993) 1.81
Prevalence of myocardial viability as detected by positron emission tomography in patients with ischemic cardiomyopathy. Circulation (1999) 1.80
8-[18F]Fluoropenciclovir: an improved reporter probe for imaging HSV1-tk reporter gene expression in vivo using PET. J Nucl Med (2001) 1.80
Epileptic patterns of local cerebral metabolism and perfusion in humans determined by emission computed tomography of 18FDG and 13NH3. Ann Neurol (1980) 1.78
13N ammonia myocardial imaging at rest and with exercise in normal volunteers. Quantification of absolute myocardial perfusion with dynamic positron emission tomography. Circulation (1989) 1.77
Cerebral metabolism and atrophy in Huntington's disease determined by 18FDG and computed tomographic scan. Ann Neurol (1982) 1.77
Metabolic mapping of the brain's response to visual stimulation: studies in humans. Science (1981) 1.75
Binding characteristics of radiofluorinated 6-dialkylamino-2-naphthylethylidene derivatives as positron emission tomography imaging probes for beta-amyloid plaques in Alzheimer's disease. J Neurosci (2001) 1.73
Comparative localization of epileptic foci in partial epilepsy by PCT and EEG. Ann Neurol (1982) 1.73
Oestrogen receptors and the response to endocrine therapy in advanced breast cancer. Br J Cancer (1978) 1.71
High-resolution microPET imaging of carcinoembryonic antigen-positive xenografts by using a copper-64-labeled engineered antibody fragment. Proc Natl Acad Sci U S A (2000) 1.69
Cerebral glucose metabolic rates in nondepressed patients with obsessive-compulsive disorder. Am J Psychiatry (1988) 1.68
Novel observations with FDOPA-PET imaging after early nigrostriatal damage. Mov Disord (2001) 1.68
Absence of infection in breast-fed infants born to hepatitis C virus-infected mothers. J Pediatr (1995) 1.67
Multiple cis elements regulate an alternative splicing event at 4.1R pre-mRNA during erythroid differentiation. Blood (2001) 1.66
Clinical utility of positron emission tomography with 18F-fluorodeoxyglucose in detecting residual/recurrent squamous cell carcinoma of the head and neck. AJNR Am J Neuroradiol (1998) 1.64
Randomised comparison of 5 years of adjuvant tamoxifen with continuous therapy for operable breast cancer. The Scottish Cancer Trials Breast Group. Br J Cancer (1996) 1.64
Oestrogen receptor concentration in primary breast cancer and axillary node metastases. Breast Cancer Res Treat (1981) 1.64
Functional anatomy of human procedural learning determined with regional cerebral blood flow and PET. J Neurosci (1992) 1.64
Intrascleral dissemination of infectious scleritis following pterygium excision. Br J Ophthalmol (1998) 1.63
Assays for noninvasive imaging of reporter gene expression. Nucl Med Biol (1999) 1.62
Use of the abdominal aorta for arterial input function determination in hepatic and renal PET studies. J Nucl Med (1992) 1.59
Metabolic and functional recovery of ischemic human myocardium after coronary angioplasty. J Am Coll Cardiol (1991) 1.57
Monitoring gene therapy with reporter gene imaging. Semin Nucl Med (2001) 1.56
Quantification of target gene expression by imaging reporter gene expression in living animals. Nat Med (2000) 1.56
Relation among stenosis severity, myocardial blood flow, and flow reserve in patients with coronary artery disease. Circulation (1995) 1.54
A simplified method for quantification of myocardial blood flow using nitrogen-13-ammonia and dynamic PET. J Nucl Med (1993) 1.53
Measurements of substrate uptake by mammary gland of the rat. Biochem J (1972) 1.51
Reduced cerebral glucose metabolism in asymptomatic subjects at risk for Huntington's disease. N Engl J Med (1987) 1.51
Regional myocardial blood flow and metabolism at rest in mildly symptomatic patients with hypertrophic cardiomyopathy. J Am Coll Cardiol (1989) 1.51
Purine transport in polymorphonuclear leukocytes. Biochim Biophys Acta (1969) 1.51
Brain metabolic changes in major depressive disorder from pre- to post-treatment with paroxetine. Psychiatry Res (1999) 1.51
A novel role of metalloproteinase in cancer-mediated immunosuppression. Cancer Res (2001) 1.49
Effect of eicosapentaenoic acid and other fatty acids on the growth in vitro of human pancreatic cancer cell lines. Br J Cancer (1994) 1.48
Systematic changes in cerebral glucose metabolic rate after successful behavior modification treatment of obsessive-compulsive disorder. Arch Gen Psychiatry (1996) 1.47
Prediction of residual neoplasia based on histopathology and margin status of conization specimens. Gynecol Oncol (1996) 1.47
The fluorodeoxyglucose 18F scan in Alzheimer's disease and multi-infarct dementia. Arch Neurol (1983) 1.47
A quantitative index of regional blood flow in canine myocardium derived noninvasively with N-13 ammonia and dynamic positron emission tomography. J Am Coll Cardiol (1991) 1.46
The effect of acetoacetate on plasma insulin concentration. Biochem J (1971) 1.44
Influence of cognitive status, age, and APOE-4 genetic risk on brain FDDNP positron-emission tomography imaging in persons without dementia. Arch Gen Psychiatry (2009) 1.44